Physician profile
Pavankumar Thota
NPI 1013478668
$2,625.57
in general payments reported to CMS, 2019-2025
17 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.35 · 2023: $15.31 · 2024: $1,049 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,364 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,364.35 |
| Education | $236.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $564.12 | 2024-2025 | Lifevest |
| Novo Nordisk INC | $498.20 | 2024-2025 | Wegovy, Ozempic |
| Abbott Laboratories | $440.13 | 2023-2025 | Ensite, Assurity, Cardiomems |
| Kestra Medical Technology Services, INC. | $366.60 | 2024-2025 | Assure Wcd |
| Pfizer INC. | $133.87 | 2022-2025 | |
| Amgen INC. | $116.89 | 2022-2025 | Repatha, Repatha |
| Abiomed | $101.66 | 2024-2025 | Impella |
| Medtronic, INC. | $94.26 | 2025 | Micra, Azure Xt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.66 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $57.86 | 2025 | Camzyos |
| Boston Scientific Corporation | $43.42 | 2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $34.94 | 2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $29.94 | 2024 | Xarelto |
| Inari Medical, INC. | $23.93 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alnylam Pharmaceuticals INC. | $23.49 | 2024 | Onpattro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $18.43 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavankumar Thota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.